Cabazitaxel for castration-resistant prostate cancer
- PMID: 21215876
- DOI: 10.1016/S0140-6736(11)60012-3
Cabazitaxel for castration-resistant prostate cancer
Comment on
-
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial.Lancet. 2010 Oct 2;376(9747):1147-54. doi: 10.1016/S0140-6736(10)61389-X. Lancet. 2010. PMID: 20888992 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
